1.Synovial Sarcoma Mimicking Myositis Ossificans
Mehmet Sabri BALIK ; Adem ERKUT ; Yılmaz GUVERCIN ; Recep BEDIR
The Journal of Korean Knee Society 2016;28(3):249-252
A calcification mass was incidentally found in the soft tissue of a patient who had a history of trauma to the extremity during examination. The patient had no symptom. The pathological analysis of the mass revealed it was an early-phase synovial sarcoma (SS). The diagnosis was made before the onset of symptoms and proper surgical intervention was performed. Therefore, in case of a <1 cm lesion clinically suspicious of myositis ossificans, SS should be taken into consideration as a possible diagnosis.
Diagnosis
;
Extremities
;
Femur
;
Humans
;
Myositis Ossificans
;
Myositis
;
Sarcoma, Synovial
2.Is the Mean Platelet Volume Predictive of Hip Fractures in the Elderly?.
Erkan CURE ; Mehmet Sabri BALIK ; Medine CUMHUR CURE ; Yilmaz GUVERCIN ; Adem ERKUT ; Suleyman YUCE ; Davut KESKIN
Annals of Laboratory Medicine 2013;33(5):367-370
No abstract available.
Aged
;
Aged, 80 and over
;
Blood Platelets/*cytology
;
Chronic Disease
;
Female
;
Fractures, Bone/diagnosis
;
Hemoglobins/analysis
;
Hip Fractures/*diagnosis
;
Humans
;
Male
;
*Mean Platelet Volume
;
Risk Factors
3.Quadriceps Tendon Rupture due to Postepileptic Convulsion
Mehmet Sabri BALIK ; Adem ERKUT ; Yilmaz GUVERCIN ; Rifat SAHIN ; Davut KESKIN
The Journal of Korean Knee Society 2014;26(2):114-116
We present a case of quadriceps tendon (QT) rupture. QT ruptures can occur in all ages. The cause is mostly traumatic in origin. Spontaneous ruptures that are thought to result from predisposing conditions are rare. Post-convulsion QT ruptures lacking traumas in their history can be overlooked in clinical examinations. This should be born in mind by the attending physician, as early diagnosis and treatment of the condition can lead to satisfactory outcomes.
Early Diagnosis
;
Epilepsy
;
Knee Joint
;
Rupture
;
Rupture, Spontaneous
;
Seizures
;
Tendon Injuries
;
Tendons
4.Increased Bladder Wall Thickness in Diabetic and Nondiabetic Women With Overactive Bladder.
Hakki UZUN ; Sabri OGULLAR ; Serap Baydur SAHIN ; Orhan Unal ZORBA ; Gorkem AKCA ; Fatih SUMER ; Ulku Mete GUNEY ; Gulsah BALIK
International Neurourology Journal 2013;17(2):67-72
PURPOSE: Bladder wall thickness has been reported to be associated with overactive bladder (OAB) in women. Diabetic women have an increased risk for OAB syndrome and may have an increased risk for bladder wall thickness. METHODS: A total of 235 female patients aged 40 to 75 years were categorized into four groups. The first group consisted of women free of urgency or urge urinary incontinence. The second group included nondiabetic women with idiopathic OAB. The third group consisted of women with diabetes and clinical OAB, and women with diabetes but without OAB constituted the fourth group. Bladder wall thickness at the anterior wall was measured by ultrasound by the suprapubic approach with bladder filling over 250 mL. RESULTS: The diabetic (third group) and nondiabetic (second group) women with OAB had significantly greater bladder wall thickness at the anterior bladder wall than did the controls. However, the difference was not significant between the diabetic (third group) and the nondiabetic (second group) women with OAB. Women with diabetes but without OAB (fourth group) had greater bladder wall thickness than did the controls but this difference was not significant. Additionally, the difference in bladder wall thickness between diabetic women with (third group) and without (fourth group) OAB was not significant. CONCLUSIONS: This is the first study to show that bladder wall thickness is increased in diabetic women with and without OAB. Additionally, nondiabetic women with OAB had increased bladder wall thickness. Further studies may provide additional information for diabetic and nondiabetic women with OAB, in whom the etiopathogenesis of the disease may be similar.
Aged
;
Diabetes Mellitus
;
Female
;
Humans
;
Urinary Bladder
;
Urinary Bladder, Overactive
;
Urinary Incontinence
5.Central Sagittal Angle of the Sacrum as a New Risk Factor for Patients with Persistent Low Back Pain after Caesarean Section.
Hizir KAZDAL ; Ayhan KANAT ; Osman Ersagun BATCIK ; Bulent OZDEMIR ; Senol SENTURK ; Murat YILDIRIM ; Leyla KAZANCIOGLU ; Ahmet SEN ; Sule BATCIK ; Mehmet Sabri BALIK
Asian Spine Journal 2017;11(5):726-732
STUDY DESIGN: Retrospective. PURPOSE: This study investigated the possible association of persistent low back pain (LBP) with caesarean section (CS) under spinal anesthesia. OVERVIEW OF LITERATURE: Many women suffer from LBP after CS, which is commonly performed under spinal anesthesia. However, this type of LBP is poorly understood, and there is poor consensus regarding increased risk after spinal anesthesia. METHODS: We examined two groups of patients who underwent cesarean delivery under spinal anesthesia. Group I included patients who presented to a neurosurgical clinic complaining of LBP for at least 6 months. Group II was a control group with patients without LBP. We analyzed clinical and sagittal angle parameters, including age, body mass index, parity, central sagittal angle of the sacrum (CSAS), and sacral slope (SS). RESULTS: Fifty-three patients participated in this study: 23 (43.1%) in Group I and 30 (56.9%) in Group II. Non-parametric Mann–Whitney U-tests showed that age, parity, and CSAS significantly differed between the two groups at 6 months. CONCLUSIONS: Age, parity, and CSAS appear to be associated with increased risk for LBP after CS under spinal anesthesia. Future prospective studies on this subject may help validate our results.
Anesthesia, Spinal
;
Body Mass Index
;
Cesarean Section*
;
Consensus
;
Female
;
Humans
;
Low Back Pain*
;
Parity
;
Pregnancy
;
Prospective Studies
;
Retrospective Studies
;
Risk Factors*
;
Sacrum*
6.A Comparison of the Effects of Dexamethasone and Methylprednisolone, Used on Level-3Intensive Care COVID-19 Patients, on Mortality: A Multi-Center Retrospective Study
Ahmet SARI ; Osman EKINCI ; Kemal Tolga SARAÇOĞLU ; Recep BALIK ; Mesut ASLAN ; Yelda BALIK ; Ceren ÖNAL ; Murat ASLAN ; Semra CEVHER ; Aylin PARMAKSIZ ; Şule VATANSEVER ; Münire Canan ÇICEK ; Özge Sayın AYAN ; Gaye Şensöz ÇELIK ; Açelya TOPRAK ; Mehmet YILMAZ ; Emine YURT ; Nurten BAKAN ; Selda TEKIN ; Esra ADIYEKE
Journal of Korean Medical Science 2023;38(29):e232-
Background:
Coronavirus disease 2019 (COVID-19) is often a mild disease, usually manifesting with respiratory complaints, and is sometimes mortal due to multiple organ failure. Hyperinflammation is a known COVID-19 component and is associated with organ dysfunction, disease severity and mortality. Controlling hyperinflammatory response is crucial in determining treatment direction. An important agent in providing this control is corticosteroids. This study aimed to determine whether dexamethasone and methylprednisolone, doses, administration time and duration in COVID-19 treatment are associated with improved treatment outcomes.
Methods:
This retrospective multicenter study was conducted with participation of 6 healthcare centers which collected data by retrospectively examining files of 1,340 patients admitted to intensive care unit due to COVID-19 between March 2020 and September 2021, diagnosed with polymerase chain reaction (+) and/or clinically and radiologically.
Results:
Mortality in the pulse methylprednisolone group was statistically significantly higher than that in the other 3 groups. Mortality was higher in older patients with comorbidities such as hypertension, diabetes mellitus, chronic kidney failure, coronary artery disease, and dementia. Pulse and mini-pulse steroid doses were less effective than standard methylprednisolone and dexamethasone doses, pulse steroid doses being associated with high mortality. Standard-dose methylprednisolone and dexamethasone led to similar effects, but standard dose methylprednisolone was more effective in severe patients who required mechanical ventilation (MV). Infection development was related to steroid treatment duration, not cumulative steroid dose.
Conclusion
Corticosteroids are shown to be beneficial in critical COVID-19, but the role of early corticosteroids in mild COVID-19 patients remains unclear. The anti-inflammatory effects of corticosteroids may have a positive effect by reducing mortality in severe COVID-19 patients. Although dexamethasone was first used for this purpose, methylprednisolone was found to be as effective at standard doses. Methylprednisolone administered at standard doses was associated with greater PaO 2 /FiO 2 ratios than dexamethasone, especially in the severe group requiring MV. High dose pulse steroid doses are closely associated with mortality and standard methylprednisolone dose is recommended.